US EditionStudy finds no benefit of early IABP use in cardiogenic shock patients
7 Articles
7 Articles
Study finds no benefit of early IABP use in cardiogenic shock patients
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart failure did not improve 60-day survival or enable more patients to successfully transition to long-term treatment, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultane…
MedPage Today
Anti-Aging, Acupuncture and Health NewsEnthusiasm Dries Up for Fluid Restriction in Heart Failure
(MedPage Today) -- CHICAGO -- For people with heart failure (HF), the long-presumed benefits of fluid restriction did not pan out in the FRESH-UP randomized trial. Patients showed similar changes in their Kansas City Cardiomyopathy Questionnaire...
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial
Fluid restriction is frequently recommended to patients with chronic heart failure, but randomized clinical trials assessing the effects of fluid restriction remain scarce. In this multicenter open-label trial, outpatients with chronic heart failure were randomized to receiving advice for liberal fluid intake versus receiving advice for fluid restriction, up to 1,500 ml per day of fluid intake. The primary outcome of the trial was health status …
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
